Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03453684 · ClinicalTrials.gov registry record · Phase 4
Pharmacokinetics of Preoperative Vancomycin
A Phase 4 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT03453684: Completed Phase 4 study, sponsored by University of Colorado, Denver.
NCT03453684 is a Phase 4 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 60 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03453684, a Phase 4 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
A study of plasma and tissue vancomycin pharmacokinetics in pediatric surgical patients.
Primary Outcome
Volume of the central compartment. This outcome measure was pre-specified to utilize advanced mathematical modeling for this assessment. No measure of central tendency is available.
Interventions
- DRUG Administration of Vancomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-12-01 |
| Est. Completion | 2015-07-20 |
| Phase | Phase 4 |
What the finished NCT03453684 record still lists
NCT03453684 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 1 intervention - of which Administration of Vancomycin is the first listed.
NCT03453684 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03453684 about?
NCT03453684 is a clinical study titled "Pharmacokinetics of Preoperative Vancomycin". A study of plasma and tissue vancomycin pharmacokinetics in pediatric surgical patients.
What is the current status of trial NCT03453684?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2012-12-01. Estimated completion is 2015-07-20.
What interventions are being tested in trial NCT03453684?
The interventions under investigation include: Administration of Vancomycin (DRUG).
Who is sponsoring clinical trial NCT03453684?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03453684's enrollment target sits among peer trials
60 1125th of 2000 higher than 799 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI